Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman’s Disease | NEJM
A patient with longstanding multicentric Castleman’s disease that had progressed after multiple therapies was entering hospice care. Inhibition of tumor necrosis factor will have led to remission f…